Augwave Bid 625 Tablet
Marketer
Pinewave Pharmaceuticals Pvt Ltd
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Overview Augwave Bid 625 Tablet
Cefixime 625mg tablets are a bacterial infection fighter, combating infections in various parts of the body. These include respiratory (like pneumonia), ear, sinus, urinary tract, skin, and soft tissue infections. This medication is ineffective against viral illnesses such as the common cold. To minimize stomach discomfort, take this medication with food, following your doctor's prescribed schedule for consistent dosing. Regular, evenly-spaced intake, ideally at the same time each day, aids in adherence. Dosage varies depending on the infection, but always finish the full course as directed. Premature discontinuation may allow bacterial resurgence and worsen the infection. Common side effects, usually mild, may include nausea, diarrhea, vomiting, oral or genital yeast infections, skin rashes, and vaginal inflammation. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any antibiotic allergies, kidney or liver issues, and all other medications you're currently using to your doctor, as interactions are possible. This antibiotic is generally considered safe during pregnancy and breastfeeding under medical supervision.
Uses of Augwave Bid 625 Tablet
Combating bacterial infections
Major Benefits of Augwave Bid 625 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Augwave Bid 625 Tablets should be administered with a meal.
Common Side effects of Augwave Bid 625 Tablet:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Augwave Bid 625 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Augwave Bid 625 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Augwave Bid 625 Tablet works:
Augwave Bid 625 Tablet combines Amoxycillin, an antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. Amoxycillin combats bacterial infection by disrupting the formation of their protective cell wall, crucial for bacterial survival. The Clavulanic Acid component counteracts bacterial resistance mechanisms, thereby improving Amoxycillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Augwave Bid 625 Tablet and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The use of Augwave Bid 625 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Augwave Bid 625 Tablet safely. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Augwave Bid 625 Tablet, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with kidney impairment should use Augwave Bid 625 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. This medication is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Augwave Bid 625 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Routine liver function tests are recommended during treatment.
What if you forget to take Augwave Bid 625 Tablet :
Should you forget to take your Augwave Bid 625 Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Augwave Bid 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |



